The QMN Weekly Bulletin

Aug. 3, 2012 | Vol. 4 No. 31

FDA Cites Calif. LapBand Clinic on Misleading Commercials, Billboards

Los Angeles weight-loss surgery clinic Lap-Band VIP has received an FDA warning letter for misleading marketing claims. According to the June 25 letter, the clinic misbranded the LapBand device in two television commercials and two billboards by not revealing risk information or requirements to qualify for the LapBand surgery, the June 25 letter states.
Devices & Diagnostics Letter

Register Now
Print This Page
Email This Article
RSS
Archives

Maker of Radioactive Needle Sets Warned Over Complaint Handling FDA Warns Chinese Devicemaker, Citing Lack of CAPA Triggers Novartis Gets 483 for Batch Quality Control Process Flaws Speech Therapy Devicemakers Warned Over Quality System Shortfalls

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.